Matt Zuga - CFO & Chief Business Officer at Acumen Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CFO & Chief Business Officer
Stock Symbol
ABOS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Matt Zuga - trading volume in the past year for Acumen Pharmaceuticals, Inc.

Holdings reported by Matt Zuga for Acumen Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 211K $734K $3.47 Jan 18, 2024 Direct
Employee Stock Option (right to buy) 159K Jan 2, 2024 Direct Common Stock

Transactions reported by Matt Zuga for Acumen Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.